1197944-23-2 Usage
General Description
5-bromo-7-fluoro-1H-benzo[d]iMidazole is a chemical compound that belongs to the class of benzimidazole derivatives. It is a heterocyclic compound containing a benzene ring fused to an imidazole ring, with bromine and fluorine atoms attached to specific positions on the benzene ring. 5-broMo-7-fluoro-1H-benzo[d]iMidazole has potential applications in medicinal chemistry and drug discovery, as it is known to exhibit biological activity and may act as a pharmacophore for the development of new drugs. It can also be used as a building block in organic synthesis for the preparation of various pharmaceutical and agrochemical compounds. Additionally, the presence of halogen atoms in its structure can influence its reactivity and interactions with biological targets, making it an interesting molecule for further study and research in the field of chemical and pharmaceutical sciences.
Check Digit Verification of cas no
The CAS Registry Mumber 1197944-23-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,7,9,4 and 4 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1197944-23:
(9*1)+(8*1)+(7*9)+(6*7)+(5*9)+(4*4)+(3*4)+(2*2)+(1*3)=202
202 % 10 = 2
So 1197944-23-2 is a valid CAS Registry Number.
InChI:InChI=1S/C7H4BrFN2/c8-4-1-5(9)7-6(2-4)10-3-11-7/h1-3H,(H,10,11)
1197944-23-2Relevant articles and documents
Aromatic-ring-containing compound, preparation method thereof, pharmaceutical composition and application thereof
-
, (2018/08/03)
The invention discloses an aromatic-ring-containing compound, a preparation method thereof, a pharmaceutical composition and application. The present invention provides the aromatic-ring-containing compound represented by a formula 1, a pharmaceutically acceptable salt thereof, a stereoisomer thereof, a tautomer thereof or a solvate thereof, and the aromatic-ring-containing compound can be effectively bounded to bromodomains of BRD4, BRD3, BRD2, and BRDT in BET family to regulate transcription of downstream gene c-myc and related target genes of the c-myc so as to regulate downstream signalingpathways to play specific roles including treatment of diseases such as inflammatory diseases, cancer, and AIDS. Some of the compounds have high activity, and have good cell activity and metabolic stability, so that the compounds can be an effective drug for treating tumors.
